>
公司歷程

体彩20选5中奖说明:
公司歷程2008

2008

浙江体彩20选5走式图 www.hlrqj.icu Incorporated in the PRC and commenced operation in an office

公司歷程2010

2010

Viva Biotech Shanghai was recognized as a Technically Advanced Service Enterprise.

公司歷程2013

2013

Viva Biotech Shanghai was recognized as a High-tech Enterprise.

Filed three patents on fusion expression of membrane proteins and ASMS screening methodology with purified membrane proteins.

公司歷程2017

2017

A record of 1000 new drug target proteins were studied by us with over 7000 independent crystal structures delivered. 

公司歷程2015

2015

Obtained pathogenic microorganism laboratory filing certificate.

公司歷程2012

2012

Developed G-protein-coupled receptors (“GPCR”) membrane protein targets technology platform.

公司歷程2016

2016

Commenced the construction of a research center in Jiaxing, Zhejiang Province.

公司歷程2009

2009

? Avenue Capital Group became our strategic investor.

? Established the Department of Chemistry and Department of In-vitro Assay and started providing structure-based drug discovery services.

公司歷程2014

2014

Developed a 6,000-membered library targeting GPCR and started to offer screening services.

公司歷程2011

2011

Developed a proprietary fragment compound library and the ASMS screening technology and integrated with SBDD services.

公司歷程2019

2019

Viva Biotech Holdings listed on the main board of the Hong Kong Stock Exchange. ( stock code: 1873.HK )

公司歷程2018

2018

One of our clients announced a Phase I study in patients of a compound developed from scratch with considerable effort from our scientists utilizing SBDD.